2 October 2023
The World Health Organization’s Strategic Advisory Group of Experts (SAGE) and Malaria Policy Advisory Group (MPAG) have recommended Oxford’s R21/Matrix-M™ malaria vaccine for use. The highly effective vaccine developed by the Jenner Institute and the Serum Institute of India has demonstrated high efficacy with a reassuring safety profile.
28 September 2023
A delegation from the Beijing Center for Disease Prevention and Control (Beijing CDC) visited the Chinese Academy of Medical Sciences Oxford Institute (COI) at NDM recently.
18 September 2023
A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched on 15 September 2023. This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the Pandemic Sciences Institute. It is the first trial in older people.
15 September 2023
Researchers at the Pandemic Sciences Institute (PSI) are closely monitoring the current outbreak of deadly Nipah virus in Kerala, India. To date, there have been five confirmed cases and two deaths reported, with many of those affected being family members of the first patient. The Institute has collaborations with scientists involved in the response, including virologists at the National Institute of Virology in Pune.
11 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. CCHF is on the World Health Organization's top priority watchlist for viruses that could cause a future pandemic, and yet no approved vaccines currently exist.
8 September 2023
We are delighted to announce that six researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
1 September 2023
One year on from the launch of the Ling Felce Award for the training of researchers in Oxford, we reflect on the impact of the award and the generosity of our donors.
30 August 2023
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
11 August 2023
Four major clinical trial networks, including Oxford University Clinical Research Unit, The Global Health Network, hosted by NDM’s Centre for Tropical Medicine and Global Health, based in low-resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative (GCTC) to enhance clinical research in low-resource settings.
3 August 2023
The KEMRI-Wellcome Trust Research Programme from NDM has participated in a new European-African consortium to improve the way infections in newborns are treated. This project, called SNIP-AFRICA, aims to reduce mortality among neonates in hospitals with sepsis in Africa, in an era of increasing antimicrobial resistance.
27 July 2023
PSI and the WHO Hub for Pandemic and Epidemic Intelligence will collaborate to improve the detection and tracking of infectious diseases.
24 July 2023
The R21/Matrix-M™ malaria vaccine, developed by the Jenner Institute, and manufactured by the Serum Institute of India which leverages Novavax’s adjuvant technology, has been licensed for use in Burkina Faso by the country’s regulatory agency, Agence Nationale de la Regulation Pharmaceutique.
30 June 2023
A delegation from the Ministry of Education (MoE) of the People's Republic of China visited the University of Oxford and was hosted at the Nuffield Department of Medicine (NDM) by Professor Tao Dong, Ita Askonas Professor of Translational Immunology and Director of the Chinese Academy of Medical Sciences Oxford Institute (COI).
26 June 2023
NDM’s Infectious Diseases Data Observatory and its global collaborators have developed new case report forms providing researchers with a standardised means of recording any data on visceral leishmaniasis, allowing them to compare studies and relate data to the efficacy of visceral leishmaniasis treatments from different groups of researchers.
21 June 2023
While 17 countries have now achieved trachoma elimination status, there is still work to be done, with trachoma responsible for the blindness or visual impairment of about 1.9 million people worldwide. Collaborators are being invited to join a new research project aimed at assessing the drivers for persistent and recrudescent trachoma.
20 June 2023
The annual conference of the Chinese Academy of Medical Sciences Oxford Institute took place in Chengdu, in the Sichuan province of China between 1-3 June 2023.
19 June 2023
Professor Sir John Irving Bell, Regius Professor of Medicine at the University of Oxford and former Head of Department of the Nuffield Department of Medicine, has been appointed a Companion of Honour in the King’s Birthday Honours list. He was knighted in 2015 for services to medicine, medical research and the life science industry.
15 June 2023
In order to support the Nuffield Department of Medicine in seeking out new opportunities for innovation and delivering impact across its 24 units, Prof Richard Cornall, the Head of Department, has appointed Prof Bountra in a new role within NDM Strategic.
14 June 2023
Professor Sir Peter Horby, Director of NDM's Pandemic Sciences Institute, today advised a committee at the UK Houses of Parliament of the importance of strategic scientific research funding to prepare the UK for a future pandemic, alongside Professor Bryan Charleston, Director and CEO of The Pirbright Institute.
7 June 2023
Within weeks of the pandemic starting, the Nuffield Department of Medicine (NDM) began antibody testing as part of the UK’s ONS COVID-19 Infection Survey. The platform successfully tested millions of blood samples over three years, providing invaluable information on how vaccinations and previous infections affect the chance of getting COVID-19 again.